View Full Paper

Owner Consent Verified
Case Study 4.5

Digital Identity Adoption in Pharmaceutical Firms: Roi And Performance Metrics — Evidence from Benelux

15
Pages
IEEE
Style
~ 15–22 mins
Reading Time
Impact Green Finance DevSecOps
Abstract

This case study investigates “Digital Identity Adoption in Pharmaceutical Firms: Roi And Performance Metrics — Evidence from Benelux” using a panel regression with fixed effects. Through a socio-technical lens, the analysis integrates multi-source data to derive a stakeholder-aligned blueprint for researchers and practitioners.

Download PDF Order Similar Paper Save

Digital Identity Adoption in Pharmaceutical Firms: Roi And Performance Metrics — Evidence from Benelux

ABSTRACT
Digital Identity Adoption in Pharmaceutical Firms: Roi And Performance Metrics — Evidence from Benelux is unpacked across themes: equity, risks, security, and costs. Limitations and future research paths are noted.
1
Open full preview
Related Papers
Browse all
32 Pages 4.2
Edge Computing Adoption in Esports Organizations: Privacy And Security — A Comparative Perspective
Blockchain InsurTech IoT
View Paper
14 Pages 4.3
MLOps Adoption in Supply Chain Managers: Governance And Risk — Post-Pandemic Lessons
Governance Blockchain MLOps
View Paper
36 Pages 4.4
Open Banking and Cost–Benefit Analysis among Logistics Hubs in Europe — A Comparative Perspective
Leadership Data Privacy Climate
View Paper